Abstract
The search for opioid binding sites on leukocytes has been difficult. The presence of opioid binding sites has been reported on human and murine leukocytes (1–3) as well as on some cell lines (4,5). However, in contrast to brain opioid receptors, these sites do not exhibit all of the classical opioid binding characteristics, such as stereoselectivity and high affinity for both alkaloids and peptides (6). In addition, agonist-induced functional responses have not been correlated with these binding sites. It seems likely that only a small population of leukocytes actually express opioid receptors, and possibly only under certain conditions. If this is the case, binding studies with mixed cell populations may not show a detectable signal-to-noise ratio, even when receptors are present.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. J. Madden, R. M. Donahoe, J. Zwemer-Collins, D. A. Shafer and A. Falek, Binding of naloxone to human T lymphocytes, Biochem. Pharmacol. 36: 4103–4109 (1987).
H. Ovadia, P. Nitsan and O. Abramsky, Characterization of opiate binding sites on membranes of rat lymphocytes,.J. Neuroimmunol. 21:93–102 (1989).
S. Roy, B.-L. Ge, S. Ramakrishnan, N. M. Lee and H. H. Loh, [3H]Morphine binding is enhanced by IL-1-stimulated thymocyte proliferation, FEBS Lett. 287: 93–96 (1991).
E. Fiorica and S. Spector, Opioid binding site in EL-4 thymoma cell line. Life Sci. 42:199–206 (1988).
D. J. J. Carr, B. R. DeCosta, C.-H. Kim, A. E. Jacobson, V. Guarcello, K. C. Rice and J. E. Blalock, Opioid receptors on cells of the immune system: evidence for δ- and K-classes, J. Endocrinol. 122:161–168 (1989).
N. E. S. Sibinga and A. Goldstein, Opioid peptides and opioid receptors in cells of the immune system, Ann. Rev. Immunol. 6:219–249 (1988).
J. M. Bidlack, L. D. Saripalli and D. M. P. Lawrence, κ-Opioid binding sites on a murine lymphoma cell line, Eur. J. Pharmacol. 227:257–265 (1992).
D. M. P. Lawrence and J. M. Bidlack, The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein, J. Pharmacol. Exp. Ther 266:1678–1683 (1993).
P. Ralph, Retention of lymphocyte characteristics by myelomas and θ+-lymphomas: sensitivity to cortisol and phytohemagglutinin, J. Immunol. 110:1470–1475 (1973).
R. S. Zukin, M. Eghbali, D. Olive, E. M. Unterwald and A. Tempel, Characterization and visualization of rat and guinea pig brain K opioid receptors: evidence for κ1 and κ2 opioid receptors, Proc. Natl. Acad. Sci. U.S.A. 85:4061–4065 (1988).
J. A. Clark, L. Liu, M. Price, B. Hersh, M. Edelson and G. W. Pasternak, Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive κ1 subtypes and a novel κ3 subtype, J. Pharmacol. Exp. Ther 251:461–468 (1989).
G. P. Brown, K. M. Standifer and G. W. Pasternak, Biochemical characterization of κ1 opiate binding sites in R1.1 thymoma cells, Soc. Neurosci. Abstr 19:1154 (1993).
D. M. P. Lawrence, D. B. Joseph and J. M. Bidlack, Kappa opioid receptors expressed on three related thymoma cell lines: differences in receptor-effector coupling, Biochem. Pharmacol. 49:81–89 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bidlack, J.M., Joseph, D.B., Lawrence, D.M.P. (1995). Kappa Opioid Receptors on Three Related Thymoma Cell Lines. In: Sharp, B.M., Eisenstein, T.K., Madden, J.J., Friedman, H. (eds) The Brain Immune Axis and Substance Abuse. Advances in Experimental Medicine and Biology, vol 373. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1951-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1951-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5801-5
Online ISBN: 978-1-4615-1951-5
eBook Packages: Springer Book Archive